Edition:
United States

Ventas Realty LP (VTRB.N)

VTRB.N on New York Stock Exchange

24.52USD
2 Dec 2016
Change (% chg)

$-0.21 (-0.85%)
Prev Close
$24.73
Open
$24.51
Day's High
$24.53
Day's Low
$24.51
Volume
1,728
Avg. Vol
6,038
52-wk High
$28.19
52-wk Low
$23.52

Latest Key Developments (Source: Significant Developments)

Ventas expects loan to be accretive to 2017 normalized funds
Wednesday, 5 Oct 2016 04:01pm EDT 

Ventas Inc : To provide secured debt financing of $700 million to unit of Ardent Health Services in connection with Ardent's agreement to buy LHP Hospital Group . Ventas issues secured debt financing commitment for ardent health services to merge with LHP Hospital Group, Inc. . Ventas expects loan to be accretive to 2017 normalized funds from operations on a leverage neutral basis .Expects to fund transaction using proceeds of asset sales and loan repayments, cash on hand and other capital sources.  Full Article

Ardent Health Services and LHP Hospital Group announce plans to merge
Wednesday, 5 Oct 2016 04:00pm EDT 

Ardent Health Services : Ardent Health Services and Lhp Hospital Group, Inc announce plans to merge . Terms of transaction were not disclosed . Under terms of agreement, co will assume LHP's management, operational responsibilities within each joint venture partnership . Ardent health services and LHP Hospital Group, Inc announce plans to merge .Transaction is not expected to impact day-to-day operations of affiliated hospitals.  Full Article

Ventas believes investigation by SEC is over
Monday, 26 Sep 2016 04:56pm EDT 

Ventas Inc : SEC investigation regarding co's former accounting firm's determination that it was not independent of Co completed with no action against Co . Believes investigation by SEC regarding Co's former registered public accounting firm has been completed - SEC filing . Says on Sept 21, Co received letter from SEC staff indicating that SEC staff has concluded investigation as to co related to matter Further company coverage: [VTR.N] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Care Capital Properties Q2 adjusted FFO per share $0.79
Thursday, 11 Aug 2016 07:32am EDT 

Care Capital Properties Inc : Q2 adjusted FFO per share $0.79 . Q2 FFO per share $0.77 . Care capital properties reports second quarter 2016 results . Sees FY 2016 adjusted FFO per share $2.92 to $2.98 . 2016 National Association of Real Estate Investment Trusts (NAREIT) FFO range is now expected to be between $2.85 and $2.91 per diluted common share . Raising its 2016 normalized FFO guidance range to $2.92 to $2.98 per diluted common share . Q2 FFO per share view $0.76 -- Thomson Reuters I/B/E/S . Raises 2016 guidance . 2016 NAREIT FFO range is now expected to be between $2.85 and $2.91 per diluted common share .FY2016 FFO per share view $2.93 -- Thomson Reuters I/B/E/S.  Full Article

Ventas issued and sold 10.2 mln shares of its common stock
Monday, 11 Jul 2016 04:32pm EDT 

Ventas Inc : Issued and sold 10. 2 million shares of its common stock, par value $0.25 per share - SEC filing .Ventas inc says expects to receive net proceeds from the offering of about $735.3 million after deducting its estimated expenses.  Full Article

Ventas announces pricing of common stock offering
Tuesday, 5 Jul 2016 09:01pm EDT 

Ventas Inc : Ventas announces pricing of common stock offering . J.P. Morgan is serving as sole underwriter for offering . Says offering 9 million common shares .Intends to use proceeds from offering to fund portion of $1.5 billion purchase price of real estate portfolio of Wexford Science & Technology.  Full Article

Ventas announces public offering of 9 mln shares of common stock
Tuesday, 5 Jul 2016 04:32pm EDT 

Ventas Inc : Ventas announces public offering of 9,000,000 shares of common stock . Company has also granted underwriter a 30-day option to purchase up to an additional 1.4 million shares of common stock .Intends to use net proceeds to fund portion of $1.5 billion purchase price of its pending acquisition of real estate portfolio of Wexford Science & Technology.  Full Article

Ventas to buy life science and medical real estate assets of Wexford Science
Tuesday, 5 Jul 2016 04:29pm EDT 

Ventas Inc : Total consideration for transaction is $1.5 billion plus assumption of $33 million of liabilities . Total consideration for 23 operating properties is $1.4 billion . Company is also acquiring nine development sites principally contiguous to existing assets . Transaction expected to be accretive in 2017 by $0.07 to $0.09 per share to normalized ffo . Definitive agreement to acquire substantially all of life science and medical real estate assets of wexford science & technology, llc .Wexford will continue to manage portfolio.  Full Article

Ventas says priced $400 mln of 3.125% senior notes due 2023
Wednesday, 25 May 2016 07:20pm EDT 

Ventas Inc : Says priced a public offering of $400 million aggregate principal amount of 3.125% senior notes due 2023 .Ventas announces pricing of senior notes offering.  Full Article

Ventas commences tender offer for 1.55% senior notes due 2016
Wednesday, 25 May 2016 08:58am EDT 

Ventas Inc : Ventas commences tender offer for 1.55% senior notes due 2016 .Commenced a cash tender offer for any and all of its outstanding $550,000,000 aggregate principal amount of its 1.55% senior notes due 2016.  Full Article

Fitch Rates Ventas' 2026 Senior Unsecured Notes 'BBB+'; Outlook Stable

(The following statement was released by the rating agency) NEW YORK, September 14 (Fitch) Fitch Ratings has assigned a 'BBB+' rating to the senior unsecured notes due 2026 issued by Ventas Realty, L.P. (Issuer Default Rating 'BBB+'/Outlook Stable), the operating partnership of Ventas, Inc. (NYSE: VTR). A full list of ratings follows at the end of this release. KEY RATING DRIVERS The 'BBB+' rating and Stable Outlook reflect Ventas' diverse portfolio of healthcare properties, demonstrated an